Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction
Sponsored by HaEmek Medical Center, Israel
About this trial
Last updated 10 years ago
Study ID
006-07-EMC
Status
Completed
Type
Observational
Placebo
No
Accepting
18 to 75 Years
All Sexes
Trial Timing
Ended 18 years ago
What is this trial about?
Overt hyperthyroidism and hypothyroidism are associated with inverted hemodynamic changes.Regional blood flow disturbances (including intrathyroidal) were also reported in these thyroid disorders. The purpose of this study is to investigate the thyroid vascularity and blood flow by Color Flow Doppler Sonography in patients with subclinical thyroid dysfunction
What are the participation requirements?
Inclusion Criteria
* patients with subclinical hypothyroidism or hyperthyroidism
* patients with thyroid nodules and normal thyroid function
Exclusion Criteria
* patients who are taking thyroxine, antithyroid drugs, lithium or amiodarone
* patients who had thyroid surgery or radioiodine therapy
* patients with NYHA class 3 or 4 heart failure